J. Ren

发表

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

J. Cuzick, H. Brenner, E. Kuipers, 2012, Endoscopy.

P1-301 A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005

J. Ferlay, F. Bray, K. Saika, 2011, Journal of Epidemiology & Community Health.

Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program

F. Tan, Wanqing Chen, Ni Li, 2022, Chinese medical journal.

[Analysis for the breast cancer screening among urban populations in China, 2012-2013].

M. Dai, J. Ren, Y. Wang, 2016, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey

Ni Li, M. Dai, J. Ren, 2017, Chinese journal of cancer.

Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis

Ni Li, J. Ren, Jufang Shi, 2020, Prostate Cancer and Prostatic Diseases.

[China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing)].

J. Ren, J. He, W. Q. Chen, 2022, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Medical expenses of urban Chinese patients with stomach cancer during 2002–2011: a hospital-based multicenter retrospective study

M. Dai, J. Ren, Yuqin Liu, 2018, BMC Cancer.

Association between baseline C-reactive protein and the risk of lung cancer: a prospective population-based cohort study.

Shuohua Chen, Ni Li, Jiang Li, 2022, Cancer Prevention Research.

[Total cholesterol and the risk of primary liver cancer in Chinese males: a prospective cohort study].

M. Dai, J. Ren, G. Wang, 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[Metabolic syndrome components and renal cell cancer risk in Chinese males: a population-based prospective study].

M. Dai, J. Ren, G. Wang, 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

Medical expenditure for liver cancer in urban China: A 10-year multicenter retrospective survey (2002–2011)

Shou-Ling Wu, Guangyu Hu, M. Dai, 2018, Journal of cancer research and therapeutics.

[Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].

M. Dai, J. Ren, W. Q. Chen, 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[Constituent and workload of service providers engaged in cancer screening: findings and suggestions from a multi-center survey in China].

M. Dai, J. Ren, J. He, 2018, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[Willingness and preferences of actual service suppliers regarding cancer screening programs: a multi-center survey in urban China].

M. Dai, J. Ren, J. He, 2018, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].

M. Dai, J. Ren, W. Q. Chen, 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

A strategy to reduce the false‐positive rate after low‐dose computed tomography in lung cancer screening: A multicenter prospective cohort study

F. Tan, Jiang Li, Chenran Wang, 2023, Cancer medicine.

Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.

Q. Ouyang, Shengtao Zhu, J. Ren, 2023, Journal of cancer research and clinical oncology.

[China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)].

J. Ren, J. He, W. Q. Chen, 2022, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[Economic burden of stomach cancer in China during 1996-2015: a systematic review].

M. Dai, J. Ren, P. Lou, 2017, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].

Y. Liu, F. Tan, M. Dai, 2021, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

Understanding mammographic breast density profile in China: A Sino‐Australian comparative study of breast density using real‐world data from cancer screening programs

P. Brennan, R. Heard, M. Dai, 2022, Asia-Pacific journal of clinical oncology.

[Study on the health literacy and related factors of the cancer prevention consciousness among urban residents in China from 2015 to 2017].

Y. Liu, Y. Wang, M. Dai, 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[Cancer screening service utilization and willingness-to-pay of urban populations in China: a cross-sectional survey from potential service demander's perspective].

M. Dai, J. Ren, J. He, 2018, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].

S. Zou, M. Dai, J. Ren, 2018, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

Modifiable risk‐attributable and age‐related burden of lung cancer in China, 1990–2019

F. Tan, Kaiyong Zou, Chenran Wang, 2023, Cancer.

International trends in primary liver cancer incidence from 1973 to 2007

Ni Li, M. Dai, J. Ren, 2015, BMC Cancer.

[Population's acceptance and attitude toward a novel fecal immunochemical test for colorectal cancer screening: a multi-center survey in China].

J. Chai, M. Dai, J. Ren, 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].